Infliximab in Takayasu arteritis: A safe alternative?

Clinical Rheumatology

Volumn 26, Issue 6, 2007, Pages 984-987

  Karageorgaki, Zaharenia Th ^a   Mavragani, Clio P ^a,c   Papathanasiou, Matthilde A ^a   Skopouli, Fotini N ^b  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b First Department of Ophthalmology   (Greece)

^c HOSPITAL FOR SPECIAL SURGERY   (United States)

Author keywords

Granulomatous inflammation; Infliximab; Takayasu arteritis; Therapy

Indexed keywords

ACETYLSALICYLIC ACID; ANTIBIOTIC AGENT; AZATHIOPRINE; C REACTIVE PROTEIN; CD20 ANTIBODY; CYCLOPHOSPHAMIDE; CYCLOSPORIN; FOLIC ACID; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE;

ADOLESCENT; ADULT; ANEURYSM; ANTIBODY PRODUCTION; AORTA ARCH SYNDROME; ARTERIOGRAPHY; ARTICLE; CAROTID ARTERY OBSTRUCTION; CASE REPORT; CLINICAL ASSESSMENT; CLINICAL FEATURE; DRUG DOSE ESCALATION; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG ERUPTION; DRUG MEGADOSE; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HAIR LOSS; HUMAN; LASER COAGULATION; LOW DRUG DOSE; OPHTHALMOSCOPY; PRIORITY JOURNAL; RETINA NEOVASCULARIZATION; UPPER RESPIRATORY TRACT INFECTION;

ADOLESCENT; ADULT; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; TAKAYASU'S ARTERITIS; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34250778462     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-006-0227-0     Document Type: Article

References (18)

1. Kerr GS, Hallahan CW, Giordano J, Leavitt RY, Fauci AS, Rottem M, Hoffman GS (1994) Takayasu arteritis. Ann Intern Med 120:919-929
2. Johnston SL, Lock RJ, Gompels MM (2002) Takayasu arteritis: A review. J Clin Pathol 55:481-486
3. Shelhamer JH, Volkman DJ, Parillo JE, Lawley TJ, Johnston MR, Fauci AS (1985) Takayasu's arteritis and its therapy. Ann Intern Med 103:121-126
4. Hoffman GS, Leavitt RY, Kerr GS, Rottem M, Sneller MC, Fauci AS (1994) Treatment of glucocorticoid-resistant or relapsing Takayasu arteritis with methotrexate. Arthritis Rheum 37:578-582
5. Sabbadini MG, Bozzolo E, Baldissera E, Bellone M (2001) Takayasu's arteritis: Therapeutic strategies. J Nephrol 14:525-531
6. Noris M (2001) Pathogenesis of Takayasu's arteritis. J Nephrol 14:506-513
7. Noguchi S, Numano F, Gravanis MB, Wilkox JN (1998) Increased levels of soluble forms of adhesion molecules in Takayasu arteritis. Int J Cardiol 66(Suppl 1):S23-S33
8. Sneller MC (2002) Granuloma formation, implications for the pathogenesis of vasculitis. Clevel Clin J Med 69(Suppl 2):SII40-SII43
9. Lipsky PE, van der Heijde DM, St Clair EW, Furst DE, Breedveld FC, Kalden J et al (2000) Anti-tumor necrosis factor trial in rheumatoid arthritis with concomitant Therapy Study Group: Infliximab and methotrexate in the treatment of rheumatoid arthritis. N Engl J Med 343:594-602
10. Emery P (2001) Infliximab: A new treatment for rheumatoid arthritis. Hosp Med 62:150-152
11. Antoni C, Manger B (2002) Infliximab for psoriasis and psoriatic arthritis. Clin Exp Rheumatol 20(6 Suppl 28):S122-S125
12. Cherouvim, EP, Zintzaras E, Boki, KA, Moutsopoulos HM, Manoussakis MN (2004) Infliximab therapy for patients with active and refractory spondyloarthropathies at the dose of 3 mg/kg: A 20-month open treatment. J Clin Rheumatol 10(4):162-168
13. Braun J, Brandt J, Listing J, Zink A, Alten R, Golder W, Gromnica-Ihle E, Kellner H, Krause A, Schneider M, Sorensen H, Zeidler H, Thriene W, Sieper J (2002) Treatment of active ankylosing spondylitis with infliximab: A randomized controlled multicentre trial. Lancet 359:1187-1193
14. Bartolucci P, Ramanoelina J, Cohen P, Mahr A, Godmer P, Le Hello C et al (2002) Efficacy of the anti-TNF-alpha antibody infliximab against refractory systemic vasculitides: An open pilot study on 10 patients. Rheumatology (Oxford) 1:1126-1132
15. Cantini F, Niccoli L, Salvarani C, Padula A, Olivieri I (2001) Treatment of longstanding active giant cell arteritis with infliximab: Report of four cases. Arthritis Rheum 44:2933-2935
16. Sfikakis PP, Theodossiadis PG, Katsiari CG, Kaklamanis P, Markomichelakis NN (2001) Effect of infliximab on sight-threatening panuveitis in Behcet's disease. Lancet 28(358):295-296
17. Lamprecht P, Voswinkel J, Lilienthal T, Nolle B, Heller M, Gross WL et al (2002) Effectiveness of TNF-alpha blockade with infliximab in refractory Wegener's granulomatosis. Rheumatology (Oxford) 41:1303-1307
18. Hoffman GS, Merkel PA, Brasington RD, Lenschow DJ, Liang P (2004) Anti-tumor necrosis factor therapy in patients with difficult to treat Takayasu arteritis. Arthritis Rheum 50:2296-2304